Disease Progression  >>  oxaliplatin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
ML18147, NCT00700102 / 2006-004634-32: A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.

Checkmark ASCO-GI 2014
Jan 2014 - Jan 2014: ASCO-GI 2014
Checkmark P2 data - CRC
Jul 2013 - Jul 2013: P2 data - CRC
Checkmark ASCO-GI 2013
More
Completed
3
820
Europe, RoW
Chemotherapy, Bevacizumab, Avastin
Hoffmann-La Roche
Colorectal Cancer
05/13
05/13
PANUSCO, NCT01362582: Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer

Terminated
3
32
Europe
SMOF Kabiven
National Center for Tumor Diseases, Heidelberg, Heidelberg University
Pancreatic Cancer
08/14
09/14
AIO-KRK-0207, NCT00973609 / 2008-007974-39: Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)

Checkmark ESMO 2016
Oct 2016 - Oct 2016: ESMO 2016
Checkmark ESMO 2014
Sep 2014 - Sep 2014: ESMO 2014
Checkmark ASCO 2014
More
Completed
3
853
Europe
5-Fluorouracil, Folic acid, Capecitabine; Bevacizumab
AIO-Studien-gGmbH, Roche Pharma AG
Colorectal Neoplasms
12/14
08/15
BOS3, NCT01646554: Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases

Withdrawn
2/3
0
NA
Modified FOLFOX6, 5-FU, folinic acid, oxaliplatin, Aflibercept, Surgery
European Organisation for Research and Treatment of Cancer - EORTC, Sanofi
Colorectal Cancer Metastatic, Liver Metastases, KRAS Mutated Colorectal Cancer
12/15
12/16

Download Options